Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
1 NEW February 05, 2026
A niche topic: understanding the development of hematopoietic stem cells

A niche topic: understanding the development of hematopoietic stem cells

From the Hadland and Bernstein labs, Translational Science and Therapeutics Division
Science SpotlightDecember 18, 2023
Eight Fred Hutch teams win Evergreen Fund awards

Eight Fred Hutch teams win Evergreen Fund awards

Research projects with commercial partnership potential receive grants of up to $200K
Hutch NewsDecember 13, 2022
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows

Two Fred Hutch postdocs named 2021 Damon Runyon Fellows

Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Hutch NewsAugust 13, 2021
Holding the line: low CpG content and DNA inaccessibility safeguard T cell commitment

Holding the line: low CpG content and DNA inaccessibility safeguard T cell commitment

From the Bernstein Lab, Clinical Research Division
Science SpotlightMay 17, 2021
Fred Hutch Evergreen Fund awards six grants to promising projects

Fred Hutch Evergreen Fund awards six grants to promising projects

Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Hutch NewsSeptember 22, 2020
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia

Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia

Hutch-based repository leads to lifesaving treatments for young cancer patient
Hutch NewsAugust 29, 2017
Bringing a leukemia treatment back to life with precision medicine

Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story
Hutch NewsJune 27, 2017
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
Hutch NewsDecember 03, 2015
Meeting someone who saved your life

Meeting someone who saved your life

Bone marrow transplant recipient and reunion volunteer shares story of meeting her donor
Hutch NewsJuly 23, 2015
Remembering Fred Hutch's Dr. Harold Weintraub 20 years later

Remembering Fred Hutch's Dr. Harold Weintraub 20 years later

20 years after Dr. Harold Weintraub’s death, his life — and his research — are still making a difference
Hutch NewsMay 01, 2015
Two Hutchinson Center researchers receive prestigious awards from Damon Runyon Cancer Research Foundation

Two Hutchinson Center researchers receive prestigious awards from Damon Runyon Cancer Research Foundation

Drs. Brian Till and Colleen Delaney will use the awards for immunotherapy research
News ReleasesJuly 02, 2010
Bench-to-bedside success story

Bench-to-bedside success story

Early clinical trial successes show the amazing, lifesaving potential of Colleen Delaney's unique umbilical cord-blood transplant program
Hutch NewsMarch 01, 2007
Fred Hutchinson Research Center Awarded $7 Million Grant to Lead Cancer Research Initiative

Fred Hutchinson Research Center Awarded $7 Million Grant to Lead Cancer Research Initiative

Investigation is part of the Leukemia & Lymphoma Society's $52 million global research program that seeks to find cures for blood cancers
News ReleasesOctober 02, 2002